Stay updated on BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Moscow Oblast to the Locations section and removed the Moscow Oblast Locations. The page revision was updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:58:06.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:59:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now includes an updated note that PubMed publications are automatically filled from PubMed and may not all be about the study. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:35:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Removal of a general government funding status notice from the page; no study data, eligibility criteria, or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:38:17.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    No significant additions or deletions detected; the Study Details page content appears unchanged across screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:14:28.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T10:09:13.000Z thumbnail image

Stay in the know with updates to BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.